IMAAVY Approval for wAIHA @checkrare
IMAAVY Approval for wAIHA  @checkrare
Uploaded September 2026 | Updated November 2026, 3 hours ago
Karen A. Jones, EdD, President and CEO of wAIHA Warriors, discusses the approval of Imaavy (nipocalimab) and its impact on patients with warm autoimmune hemolytic anemia (wAIHA).
IMAAVY Approval for wAIHAFDA Approves Multiple Myeloma Drug;  FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-W...FDA Approves Rare Disease Treatments as Huntington’s Gene Therapy AdvancesNew Rare Disease Center of Excellence and FDA Advances in Rare DiseaseEXPAND Study on Ultra-Rare Cholestatic Liver DiseaseFDA Approves New Narcolepsy TreatmentEfficacy of Infigratinib on AchondroplasiaMogamulizumab in Danish Patients With CTCLHow Bispecific Antibodies Are Changing Multiple Myeloma TreatmentThe Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseThe Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseFabry Disease: Patients Real-World Problems and How to Manage
CheckRare |

IMAAVY Approval for wAIHA

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER